Neuroprotective Effect of a Novel Herbmedicine, Hepad on SH-SY5Y Cells |
Kim, Eun Hye
(Department of Biomedical Laboratory Science, School of Medicine, Eulji University)
Park, Byung-Jun (Young Jin Korea Medical Clinic) Kim, Jung Seok (Department of Biomedical Laboratory Science, School of Medicine, Eulji University) Kim, Dong-Hee (Department of Pathology, College of Oriental Medicine, Daejeon University) Choi, Hak Joo (Department of Pathology, College of Oriental Medicine, Daejeon University) Kim, In Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University) |
1 | Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ Jr, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR. Deep brain stimulation for parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011. 68: 165. |
2 | Dauer W, Przedborski S. Parkinson' disease: mechanisms and models. Neuron 2003. 39: 889-909. DOI ScienceOn |
3 | de Lau LM, Breteler MM. Epidemiology of parkinson's disease. Lancet Neurol. 2006. 5: 525-535. DOI ScienceOn |
4 | Jain S, Wood NW, Healy DG. Molecular genetic pathways in parkinson's disease: a review. Clin Sci (Lond). 2005. 109: 355-364. DOI ScienceOn |
5 | Kidd PM. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern Med Rev. 2000. 5: 502-529. |
6 | Park BJ, Kim DH. A study on a case of treatment termination of parkinson's disease treated by 5 upright life cure regulations therapy. Institute of Oriental medicine of Dajeon University J. 2011. 19: 57-64. |
7 | Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of parkinson's disease. Mov Disord. 2001. 16: 507-510. DOI ScienceOn |
8 | Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J, Zhang J, Li LH, Xia Y, Yao LB, Qin HZ, Gao GD. Astragaloside IV prevents -induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Mol Cell Biochem. 2012. 364: 209-216. DOI ScienceOn |
9 | Blandini F, Armentero MT. Animal models of parkinson's disease. FEBS J. 2012. 279: 1156-1166. DOI |
10 | Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in parkinson's disease. Prog Neurobiol. 2001. 65: 135-172. DOI ScienceOn |